{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:19:06Z","timestamp":1792059546687,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004305","name":"Shahroud University of Medical Sciences","doi-asserted-by":"publisher","award":["9869"],"award-info":[{"award-number":["9869"]}],"id":[{"id":"10.13039\/501100004305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijbiomac.2023.125332","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:39:54Z","timestamp":1686389994000},"page":"125332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis"],"prefix":"10.1016","volume":"244","author":[{"given":"Solmaz","family":"Mahami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Vahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Sadat","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat","family":"Bitaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelwahab","family":"Omri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.125332_bb0005","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s10620-014-3437-3","article-title":"Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature","volume":"60","author":"Martin","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2019.01.018","article-title":"Ulcerative colitis","author":"Feuerstein","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ibd.22839","article-title":"Ulcerative colitis as a progressive disease: the forgotten evidence","volume":"18","author":"Torres","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0020","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0030","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"Medical progress ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0035","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/00365521.2015.1018937","article-title":"5-Aminosalicylic acid, a specific drug for ulcerative colitis","volume":"50","author":"Hauso","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f432","article-title":"Ulcerative colitis","volume":"346","author":"Ford","year":"2013","journal-title":"BMJ."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0055","first-page":"263","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"79","author":"Dignass","year":"2014","journal-title":"Rev. Gastroenterol. Mex."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0060","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","article-title":"Inflammatory bowel disease","volume":"325","author":"Podolsky","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0065","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10787-021-00856-1","article-title":"A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug","volume":"29","author":"Beiranvand","year":"2021","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.2003.01445.x","article-title":"Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation","volume":"17","author":"Brunner","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0075","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.bmcl.2004.10.098","article-title":"Synthesis of linked berberine dimers and their remarkably enhanced DNA-binding affinities","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","article-title":"The anti-inflammatory potential of berberine in vitro and in vivo","volume":"203","author":"Kuo","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0085","unstructured":"M.H. Akhter, A M.H., Anti-inflammatory effect of berberine in rats injected locally with cholera toxin, (1977)."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1139\/m69-190","article-title":"Berberine sulfate: antimicrobial activity, bioassay, and mode of action","volume":"15","author":"Amin","year":"1969","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0192-0561(89)90086-6","article-title":"Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: in vitro comparisons of tetrandrine and berbamine","volume":"11","author":"Si-Ying","year":"1989","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0192-0561(90)90088-5","article-title":"Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine","volume":"12","author":"Teh","year":"1990","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0192-0561(92)90053-N","article-title":"Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo","volume":"14","author":"Kondo","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0192-0561(96)00047-1","article-title":"Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids","volume":"18","author":"Ivanovska","year":"1996","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2006-958107","article-title":"Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium","volume":"61","author":"Mi\u0161\u00edk","year":"1995","journal-title":"Planta Med."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/iai.35.2.471-475.1982","article-title":"Berberine inhibits intestinal secretory response of vibrio cholerae and Escherichia coli enterotoxins","volume":"35","author":"Sack","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0125","series-title":"Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics","author":"Leung","year":"1980"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phyther. Res."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0135","first-page":"111","article-title":"Study of some pharmacological actions of berberine","volume":"15","author":"Sabir","year":"1971","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2005.06.028","article-title":"Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs","volume":"303","author":"Takeuchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10611860600648346","article-title":"The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin","volume":"14","author":"Thongborisute","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","article-title":"Chitosan-based delivery systems for protein therapeutics and antigens","volume":"62","author":"Amidi","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.foodcont.2017.09.021","article-title":"Insight into the antibacterial property of chitosan nanoparticles against Escherichia coli and salmonella typhimurium and their application as vegetable wash disinfectant","volume":"86","author":"Paomephan","year":"2018","journal-title":"Food Control"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jfoodeng.2015.06.010","article-title":"Production of antimicrobial chitosan nanoparticles against food pathogens","volume":"167","author":"Madureira","year":"2015","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijfoodmicro.2010.09.012","article-title":"Antimicrobial properties of chitosan and mode of action: a state of the art review","volume":"144","author":"Kong","year":"2010","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro- and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/1061186X.2011.654121","article-title":"Chitosan nanoparticles: a survey of preparation methods","volume":"20","author":"Grenha","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review","volume":"114","author":"George","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0195","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tips.2020.07.005","article-title":"Fluorescein Isothiocyanate chitosan nanoparticles in Oral drug delivery studies","volume":"41","author":"Caprifico","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2017.10.101","article-title":"Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0205","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1080\/21645515.2015.1053663","article-title":"Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery","volume":"11","author":"Farhadian","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/medicina55060294","article-title":"Preparation, optimization, and in vivo evaluation of nanoparticle-based formulation for pulmonary delivery of anticancer drug","volume":"55","author":"Chishti","year":"2019","journal-title":"Medicina (B. Aires)."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jsps.2016.12.008","article-title":"Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating","volume":"25","author":"Almalik","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0230","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1166\/jbn.2018.2596","article-title":"Berberine hydrochloride-loaded chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma","volume":"14","author":"Wang","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0235","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-3565(25)24358-0","article-title":"Acetic acid-induced colitis in normal and essential fatty acid deficient rats","volume":"272","author":"Mascolo","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0240","first-page":"1926","article-title":"Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice","volume":"23","author":"Bai","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0250","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.bjp.0704633","article-title":"Dextran sodium sulphate-induced colitis perturbs muscarinic cholinergic control of colonic epithelial ion transport","volume":"135","author":"Sayer","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0255","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of chronic inflammation and ulceration in the rat Colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0260","first-page":"15","article-title":"Anti-ulcerogenic effect of ginger (rhizome of Zingiber officinale roscoe) hydroalcoholic extract on acetic acid-induced acute colitis in rats","volume":"3","author":"Minaiyan","year":"2009","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0265","series-title":"Anti-Ulcerogenic Effect of Ginger (Rhizome of Zingiber officinale Roscoe) on Cystemine Induced Duodenal Ulcer in Rats","author":"Minaian","year":"2006"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0270","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00384-010-1026-2","article-title":"Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats","volume":"25","author":"Varshosaz","year":"2010","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0275","doi-asserted-by":"crossref","unstructured":"M. Sepehrimanesh, N. Azarpira, M. Saeb, S. Nazifi, N. Kazemipour, O. Koohi, Pathological Changes Associated with Experimental 900-MHz Electromagnetic Wave Exposure in Rats, (n.d.). doi: doi:https:\/\/doi.org\/10.1007\/s00580-013-1835-0.","DOI":"10.1007\/s00580-013-1835-0"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-8741(98)00122-6","article-title":"Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum","volume":"64","author":"Shamsa","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032084","article-title":"Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon","volume":"7","author":"Laroui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0290","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3748\/wjg.v10.i16.2311","article-title":"Drug therapy for ulcerative colitis","volume":"10","author":"Xu","year":"2004","journal-title":"World J. Gastroenterol. WJG."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5010\/JPB.2018.45.1.036","article-title":"Effect of chitosan and chitosan-nanoparticles on post harvest quality of banana fruits","volume":"45","author":"Lustriane","year":"2018","journal-title":"J. Plant Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0300","first-page":"97","article-title":"Design and characterization of mesalamine loaded nanoparticles for controlled delivery system","volume":"1","author":"Seifirad","year":"2016","journal-title":"Nanomedicine Res. J."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"European journal of pharmaceutical sciences design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0310","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tips.2020.07.005","article-title":"Fluorescein Isothiocyanate chitosan nanoparticles in Oral drug delivery studies","volume":"41","author":"Caprifico","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0315","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(95)90599-5","article-title":"Experimental models of inflammatory bowel disease acetic acid-induced colitis","volume":"109","author":"Elson","year":"1995","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0320","first-page":"24","article-title":"Protective effects of some azo derivatives of 5-aminosalicylic acid and their pegylated prodrugs on acetic acid-induced rat colitis","volume":"12","author":"Garjani","year":"2004","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0325","first-page":"G622","article-title":"Disruption of colonic electrolyte transport in experimental colitis","volume":"268","author":"Bell","year":"1995","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0330","first-page":"1","article-title":"Addition of berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL\/6 mice","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0340","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0345","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.fct.2010.01.033","article-title":"Acute toxicity of berberine and its correlation with the blood concentration in mice","volume":"48","author":"Kheir","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0350","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.0105-2896.2005.00218.x","article-title":"Tumor necrosis factor family members and inflammatory bowel disease","volume":"204","author":"Wang","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0355","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0091270007301623","article-title":"The role of TNF\u03b1 in ulcerative colitis","volume":"47","author":"Sands","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0360","first-page":"G203","article-title":"Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells","volume":"274","author":"Stein","year":"1998","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(99)00023-0","article-title":"Berberine inhibits ion transport in human colonic epithelia","volume":"368","author":"Taylor","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0370","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/08923973.2011.609887","article-title":"Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis","volume":"34","author":"Hong","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0375","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1074\/jbc.M109.012674","article-title":"Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice","volume":"284","author":"Cui","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0380","first-page":"1","article-title":"5-ASA dose-response: maximizing efficacy and adherence","volume":"6","author":"Katz","year":"2010","journal-title":"Gastroenterol. Hepatol. (N. Y)"},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0385","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/BF01296664","article-title":"Chemotactic activity in inflammatory bowel disease","volume":"32","author":"Lobos","year":"1987","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0390","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/j.1536-4801.1986.tb09200.x","article-title":"Prostaglandins in disorders of the intestinal tract: a review","volume":"5","author":"Branski","year":"1986","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0395","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/gast.2001.22470","article-title":"Enhanced survival and mucosal repair after dextran sodium sulfate\u2013induced colitis in transgenic mice that overexpress growth hormone","volume":"120","author":"Williams","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0400","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jep.2003.09.042","article-title":"Effect of polyherbal formulation on experimental models of inflammatory bowel diseases","volume":"90","author":"Jagtap","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125332_bb0405","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0016-5085(81)90594-1","article-title":"Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine","volume":"81","author":"Ligumsky","year":"1981","journal-title":"Gastroenterology."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023022262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023022262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:18:04Z","timestamp":1758881884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023022262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":79,"alternative-id":["S0141813023022262"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125332","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"125332"}}